TBL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.636200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.224400E-01
Normal-vs-Stage2
3.376800E-01
Normal-vs-Stage3
8.405800E-01
Normal-vs-Stage4
1.693590E-01
Stage1-vs-Stage2
5.288800E-01
Stage1-vs-Stage3
4.615200E-01
Stage1-vs-Stage4
5.251200E-01
Stage2-vs-Stage3
1.695770E-01
Stage2-vs-Stage4
9.706200E-01
Stage3-vs-Stage4
2.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.896800E-01
Normal-vs-AfricanAmerican
5.148200E-01
Normal-vs-Asian
3.348000E-02
Caucasian-vs-AfricanAmerican
7.777000E-01
Caucasian-vs-Asian
8.748000E-02
AfricanAmerican-vs-Asian
1.233970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.983600E-01
Normal-vs-Female
4.597200E-01
Male-vs-Female
3.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.685200E-01
Normal-vs-Age(41-60Yrs)
4.199600E-01
Normal-vs-Age(61-80Yrs)
3.861000E-01
Normal-vs-Age(81-100Yrs)
1.773390E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.478600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.368600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.732600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.130600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.808400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.516200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.837200E-01
Normal-vs-Daily Drinker
2.372800E-01
Normal-vs-Weekly Drinker
8.299600E-02
Normal-vs-Occasional Drinker
2.970400E-01
Normal-vs-Social Drinker
4.795000E-01
Non Drinker-vs-Daily Drinker
3.758000E-01
Non Drinker-vs-Weekly Drinker
5.205600E-01
Non Drinker-vs-Occasional Drinker
7.526000E-01
Non Drinker-vs-Social Drinker
6.252800E-01
Daily Drinker-vs-Weekly Drinker
7.899600E-01
Daily Drinker-vs-Occasional Drinker
6.405800E-01
Daily Drinker-vs-Social Drinker
2.810200E-01
Weekly Drinker-vs-Occasional Drinker
7.954000E-01
Weekly Drinker-vs-Social Drinker
3.217200E-01
Occasional Drinker-vs-Social Drinker
5.140000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.748600E-01
Normal-vs-Grade 2
1.548180E-01
Normal-vs-Grade 3
1.305170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.205600E-02
Grade 1-vs-Grade 3
1.689580E-02
Grade 1-vs-Grade 4
4.748600E-01
Grade 2-vs-Grade 3
1.272800E-01
Grade 2-vs-Grade 4
1.548180E-01
Grade 3-vs-Grade 4
1.305170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.857800E-01
Normal-vs-NonDiabetic
2.575200E-01
Diabetic-vs-NonDiabetic
5.953200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.154300E-02
Normal-vs-NoPancreatitis
3.486800E-01
Pancreatitis-vs-NoPancreatitis
3.680800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.488000E-01
Normal-vs-N1
4.012800E-01
N0-vs-N1
4.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.850990E-01
Normal-vs-TP53-NonMutant
7.884200E-01
TP53-Mutant-vs-TP53-NonMutant
3.017000E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
